Cellectar Biosciences, Inc. (CLRB)

Oncology Corporate Profile

Stock Performance

1.7900
0.0000

3 Month Stock History Chart

HQ Location

3301 Agriculture Drive
Madison, WI 53716

Company Description

Cellectar Biosciences is developing agents to detect, treat and monitor a broad spectrum of cancers. Utilizing a novel phospholipid ether (PLE) platform technology as a targeted delivery and retention vehicle, Cellectar's compounds are designed to be selectively taken up and retained in both cancer cells and cancer stem cells. With the ability to attach both imaging and therapeutic agents to its proprietary delivery platform, Cellectar has developed a portfolio of product candidates engineered to capitalize on the unique characteristics of cancer cells to 'find, treat and follow' malignancies in a highly selective way.

Website: http://www.cellectar.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
I-124-CLR1404positron emission tomography (PET)Glioblastoma Multiforme (GBM)II
CLR 131radiopharmaceuticalMultiple MyelomaI
CLR 131radiopharmaceuticalVarious cancer typesI

View additional information on product candidates here »

Source: http://www.cellectar.com

Recent News Headlines

8/21/2017 06:18 am

8/21/2017 06:18 am

8/15/2017 12:18 pm

8/15/2017 12:18 pm

8/14/2017 12:18 pm

8/14/2017 12:18 pm

8/8/2017 06:17 am

8/8/2017 06:17 am

8/3/2017 06:18 am

8/1/2017 06:24 am

7/31/2017 06:20 am

7/24/2017 06:18 am

7/17/2017 06:17 am

6/19/2017 06:18 am

6/15/2017 06:18 am

6/15/2017 06:18 am

6/7/2017 06:17 am

6/6/2017 06:18 am

6/6/2017 06:18 am

6/6/2017 06:18 am

6/6/2017 06:18 am

5/30/2017 06:17 am

5/30/2017 06:17 am

5/30/2017 06:17 am

5/18/2017 06:17 am